Abstract
We report a case of endocarditis due to a penicillin-"resistant" Streptococcus parasanguinis, discuss interpretations of the American Heart Association's guidelines for the treatment of viridans group streptococcal infection, and comment on therapy for infective endocarditis due to penicillin-resistant viridans group streptococci.
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Endocarditis, Bacterial / microbiology*
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Penicillin G / pharmacology*
-
Penicillin Resistance*
-
Practice Guidelines as Topic
-
Streptococcal Infections / microbiology*
-
Viridans Streptococci / drug effects*
-
Viridans Streptococci / isolation & purification*
Substances
-
Anti-Bacterial Agents
-
Penicillin G